Pavlovian conditioning to a diazepam cue with yohimbine as the unconditional stimulus

Neurobiology of Learning and Memory

Volumn 65, Issue 3, 1996, Pages 223-232

  Taukulis, Harald K ^a  

^a UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; TRANQUILIZING ACTIVITY;

EID: 0029875297     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1006/nlme.1996.0027     Document Type: Article

References (71)

1. Baldwin, H., Johnston, A. L., & File, S. E. (1989). Antagonistic effect of caffeine and yohimbine in animal tests of anxiety. European Journal of Pharmacology, 159, 211-215.
2. Barsa, J. A., & Kline, N. S. (1955). Treatment of two hundred disturbed psychotics with reserpine. Journal of the American Medical Association, 158, 110-113.
3. Bunney, B. S. (1984). Antipsychotic drug effects on the electrical activity of dopaminergic neurones. Trends in Neuroscience, 7, 210-215.
4. Carey, R. J. (1991). Pavlovian conditioning between co-administered drugs: Elicitation of an apomorphine-induced antiparkinsonian response by scopolamine. Psychopharmacology, 104, 463-469.
5. Charney, D. S., Heninger, G., & Breier, A. (1984). Noradrenergic function in panic anxiety: Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry, 41, 751-763.
6. Charney, D. S., Woods, S. W., Price, L. H., Goodman, W. K., Glazer, W. M., & Heninger, G. R. (1990). Noradrenergic dysregulation in panic disorder. In James C. Ballenger (Ed.), Neurobiology of panic disorder (pp. 91-106). New York: Wiley-Liss.
7. Colpaert, F. C., Desmedt, L. K. C., & Janssen, P. A. J. (1976). Discriminative stimulus properties of benzodiazepines, barbiturates, and pharmacologically related drugs: Relation to some intrinsic and anticonvulsant effects. European Journal of Pharmacology, 37, 113-123.
8. Commissaris, R. L., & Fontana, D. J. (1991). Pharmacological evaluation of potential animal models for the study of anti-panic and panicogenic treatment effects. In A. Boulton, G. Baker, & M. Martin-Iverson (Eds.), Neuromethods, Vol. 19: Animal models in psychiatry, II (pp. 199-232). Clifton, NJ: Humana.
9. Creese, I. (1983). Receptor interactions of neuroleptics. In J. T. Coyle & S. J. Enna (Eds.), Neuroleptics: Neurochemical, behavioral, and clinical perspectives (pp. 183-222). New York: Raven Press.
10. 1A ligands in the elevated x-maze and effects of dorsal raphe lesions. Psychopharmacology, 106, 484-490.
11. Cunningham, C. L., & Linakis, J. G. (1980). Paradoxical aversive conditioning with ethanol. Pharmacology Biochemistry & Behavior, 12, 337-341.
12. Dinan, T. G., & Aston-Jones, G. (1984). Acute haloperidol increases impulse activity of brain noradrenergic neurons. Brain Research, 307, 359-362.
13. Eikelboom, R., & Stewart, J. (1982). Conditioning of drug-induced physiological responses. Psychological Review, 89, 507-528.
14. Ferrari, F., Tartoni, P. G., Monti, A., & Mangiafico, V. (1989). Does anxiety underlie imidazole-induced behavioral effects in the rat? Psychopharmacology, 99, 345-351.
15. File, S. E., & Johnston, A. L. (1987). Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. Neuropsychobiology, 17, 187-192.
16. Garfield, S. I., Gershon, S., Sletten, I., Sundland, D. M., & Ballou, S. (1967). Chemically induced anxiety. International Journal of Neuropsychiatry, 3, 426-433.
17. 2-adrenoreceptor. Pharmacological Reviews, 35, 143-180.
18. Griebel, G. (1995). 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research. Pharmacology and Therapeutics, 65, 319-395.
19. 2-Adrenoreceptor blockade, pituitary-adrenal hormones, and agonistic interactions in rats. Psychopharmacology, 115, 478-484.
20. Handley, S. L., & Mithani, S. (1981). Effects of alpha-adrenoreceptor agonists and antagonists in a maze exploration model of "fear"-motivated behavior. Naunyn-Schmiedeberg's Archives of Pharmacology, 317, 199-203.
21. Haug, T., & Götestam, K. G. (1982). The diazepam stimulus complex: Specificity in a rat model. European Journal of Pharmacology, 80, 225-230.
22. Holmberg, G., & Gershon, S. (1961). Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia, 2, 93-106.
23. Holmberg, G., Gershon, S., & Beck, L. H. (1962). Yohimbine as an autonomic test drug. Nature, 193, 1313-1314.
24. Johansson, J. O., & Järbe, T. U. C. (1975). Diazepam as a discriminative cue: Its antagonism by bemegride. European Journal of Pharmacology, 30, 372-375.
25. Johnston, A. L., & File, S. E. (1989). Yohimbine's anxiogenic action: Evidence for noradrenergic and dopaminergic sites. Pharmacology, Biochemistry and Behavior, 32, 151-156.
26. 1A receptor agonist. Molecular Neuropharmacology, 2, 283-288.
27. Kim, J-S., & Hassler, R. (1975). Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigra. Brain Research, 88, 150-153.
28. Lett, B. T. (1983). Pavlovian drug-sickness pairings result in the conditioning of an antisickness response. Behavioral Neuroscience, 97, 779-784.
29. Lett, B. T. (1986). Conditioned slowing of stomach emptying produced by Pavlovian pairings of a drug CS or a place with lithium chloride. Psychopharmacology, 9, 49-53.
30. 1A agonists. Behavioural Pharmacology, 5, 42-51.
31. Lopez-Rubalcava, C. R., Saldivar, A., & Fernandez-Guasti, A. (1992). Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics. Pharmacology, Biochemistry, and Behavior, 43, 433-440.
32. Löscher, W., & Crzuczwar, S. J. (1986). Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. European Journal of Pharmacology, 128, 55-65.
33. Markowitz, J. C., & Brown, R. P. (1987). Seizures with neuroleptics and antidepressants. General Hospital Psychiatry, 9, 135-141.
34. 1A receptors. European Journal of Pharmacology, 199, 263-265.
35. Moises, H. C., & Woodward, D. J. (1980). Potentiation of GABA inhibitory action in cerebellum by locus coeruleus stimulation. Brain Research, 182, 327-344.
36. Molander, L. (1982). Effect of melperone, chlorpromazine, haloperidol and diazepam on experimental anxiety in human subjects. Psychopharmacology, 77, 109-113.
37. 2-adrenoreceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Archives of Pharmacology, 347, 266-272.
38. Mongeau, R., de Montigny, C., & Blier, P. (1994). Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alph-2 adrenoreceptors modulating serotonin neurotransmission. Journal of Pharmacology and Experimental Therapeutics, 269, 1152-1159.
39. Papeschi, R., & Theiss, P. (1975). The effects of yohimbine on the turnover of brain catecholamines and serotonin. European Journal of Pharmacology, 33, 1-12.
40. Pellow, S., Chopin, P., File, S., & Briley, M. (1985). Validation of open:closed arm entries in an elevated plus-maze: A novel test of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
41. Pettibone, D. J., Pfleuger, B., & Totaro, J. A. (1985). Comparison of the effects of recently-developed α2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain. Biochemical Pharmacology, 34, 1093.
42. Revusky, S. (1985). Drug interactions measured through taste aversion procedures with an emphasis on medical implications. Annals of the New York Academy of Sciences, 443, 250-270.
43. Revusky, S., Davey, V., & Zagorski, M. (1989). Heart rate conditioning with pentobarbital as a conditioned stimulus and amphetamine as an unconditioned stimulus. Behavioral Neuroscience, 103, 296-307.
44. Revusky, S., Taukulis, H. K., & Coombes, S. (1980). Dependence of the Avfail effect on the sequence of training operations. Behavioral and Neural Biology, 29, 430-445.
45. Revusky, S., Taukulis, H. K., Parker, L., & Coombes, S. (1979a). Chemical aversion therapy: Rat data suggest it may be counter-therapeutic to pair an addictive drug state with sickness. Behavior Research and Therapy, 17, 177-188.
46. Revusky, S., Taukulis, H. K., & Peddle, C. (1979b). Learned associations between drug states: Attempted analysis in Pavlovian terms. Physiological Psychology, 7, 352-363.
47. Roth, R. H. (1983). Neuroleptics: Functional neurochemistry. In J. T. Coyle and S. J. Enna (Eds.), Neuroleptics: Neurochemical, behavioral, and clinical perspectives (pp. 119-156). New York: Raven Press.
48. Scatton, B., Zivkovic, B., & Dedek, J. (1980). Antidopaminergic properties of yohimbine. Journal of Pharmacology and Experimental Therapeutics, 215, 494-499.
49. Siegel, S. (1979). The role of conditioning in drug tolerance and addiction. In J. D. Keehn (Ed.), Psychopathology in animals: Research and treatment implications (pp. 143-168). New York: Academic Press.
50. Siegel, S. (1983). Classical conditioning, drug tolerance, and drug dependence. In Y. Israel, F. B. Glaser, H. Kalant, R. E. Popham, W. Schmidt, & R. G. Smart (Eds.), Research advances in alcohol and drug problems, Vol. 7. (pp. 207-246). New York: Plenum.
51. 2-Adrenoreceptor antagonists potentiate the anticonflict and rotarod impairing effects of benzodiazepines. Journal of Neural Transmission, 76, 191-204.
52. Starke, K., Borowski, E., & Endo, T. (1975). Preferential blockade of presynaptic alpha-adrenoreceptors by yohimbine. European Journal of Pharmacology, 34, 385-388.
53. Svensson, T. H., & Usdin, T. (1978). Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: α-receptor mediation. Science, 202, 1089-1091.
54. Taukulis, H. K (1982). Attenuation of pentobarbital-elicited hypothermia in rats with a history of pentobarbital-LiCl pairings. Pharmacology, Biochemistry and Behavior, 17, 695-697.
55. Taukulis, H. K. (1986a). Conditional hyperthermia in response to atropine associated with a hypothermic drug. Psychopharmacology, 90, 327-331.
56. Taukulis, H. K. (1986b). Conditional shifts in thermic responses to sequentially paired drugs and the "conditional hyperactivity" hypothesis. Pharmacology, Biochemistry and Behavior, 25, 83-87.
57. Taukulis, H. K. (1993). Conditional attenuation of the antipentyl-enetetrazol activity of chlordiazepoxide. Pharmacology Biochemistry and Behavior, 46, 467-471.
58. Taukulis, H. K., & Brake, L. D. (1988). Conditional drug interactions: Diazepam activity following diazepam-chlorpromazine pairings. Canadian Psychology, 29(2a), 773.
59. Taukulis, H. K., & Brake, L. D. (1989). Therapeutic and hypothermic properties of diazepam altered by a diazepam-chlorpromazine association. Pharmacology, Biochemistry and Behavior, 34, 1-6.
60. Taukulis, H. K., Fillmore, M. T., & Ruggles, J. L. (1992). Neuroleptic-induced changes in the anxiolytic and myorelaxant properties of diazepam in the rat. Pharmacology, Biochemistry and Behavior, 41, 13-21.
61. Taukulis, H. K., & McKay, R. (1992). Post-drug retention of diazepam's effects on habituation to a novel environment in an animal model of anxiety. Psychobiology, 20, 286-293.
62. Turski, L., Cavalheiro, E. A., Bartolotto, Z. A., Ikonomidou-Turski, C., Kleinrok, Z., & Turski, W. A. (1988). Dopamine-sensitive anticonvulsant site in the striatum. Journal of Neuroscience, 8, 4027-4037.
63. Uhde, T. W., & Tancer, M. E. (1989). Chemical models of panic: A review and critique. In P. Tyrer (Ed.), Psychopharmacology of anxiety (pp. 109-131). Oxford: Oxford Univ. Press.
64. van Oene, J. C., de Vries, J. B., & Horn, A. S. (1984). The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology, 327, 304-311.
65. Wada, T., & Fukada, N. (1991). Effects of DN-2327, a new anxiolytic, diazepam, and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology, 104, 444-450.
66. Waldmeier, P. C., Ortmann, R., & Bischoff, S. (1982). Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: Evidence for antidopaminergic properties of some alpha antagonists. Experientia, 38, 1168-1176.
67. Waterhouse, B. D., Moises, H. C., & Woodward, D. J. (1980). Locus coeruleus stimulation potentiates somatosensory cortical neuronal responses to afferent synaptic inputs. Neuroscience, 6, 448.
68. Waterhouse, B. D., Moises, H. C., Yeh, H. H., Geller, H. M., & Woodward, D. J. (1984). Comparison of norepinephrine- and benzodiazepine-induced augmentation of Purkinje cell responses to gamma-aminobutyric acid (GABA). Journal of Pharmacology and Experimental Therapeutics, 228, 257-267.
69. Wilkin, L. D., Cunningham, C. L., & Fitzgerald, R. D. (1982). Pavlovian conditioning with ethanol and lithium: Effects on heart rate and taste aversion in rats. Journal of Comparative and Physiological Psychology, 96, 781-790.
70. Winter, J. C., & Rabin, R. A. (1992). Yohimbine as a serotonergic agent: Evidence from receptor binding and drug discrimination. Journal of Pharmacology and Experimental Therapeutics, 263, 682-689.
71. Woodward, D. J., Moises, H. C., Waterhouse, B. D., Hoffer, B. J., & Freedman, R. (1979). Modulatory actions of norepinephrine in the central nervous system. Federation Proceedings, 38, 2109-2116.